PortViewPortView
TCHP logo

T. Rowe Price Blue Chip Growth (TCHP) ETF Holdings & Analysis

ETFOther

$50.43+1.12%
1-year price historyRange $42.43 – $53.02
52-week range$50.43
$42.26$53.26

What TCHP does

The fund's core mission is to achieve substantial growth in capital over the long term. Income generation, while also pursued, is a secondary objective.

Fund profile

Category
Other
AUM
$2.23B
Holdings
10
52-week high
$53.26
52-week low
$42.26

Top holdings

Top 1060%
HoldingWeight
NVIDIA16.46%
Alphabet Class C6.55%
Broadcom6.32%
Alphabet Class A5.99%
Microsoft5.63%
Apple5.00%
Amazon.com3.90%
Meta Platforms3.57%
Carvana3.15%
Eli Lilly3.15%

Sector allocation

Basic Materials0.37%
Communication Services17.78%
Consumer Cyclical11.84%
Consumer Defensive0.03%
Financial Services6.87%
Healthcare5.91%
Industrials5.27%
Technology51.56%
Utilities0.37%

Geographic allocation

United States93.36%
Netherlands1.38%
Switzerland0.95%
Taiwan0.93%
Canada0.89%
South Korea0.86%
Singapore0.48%
Other0.42%
Ireland0.41%
United Kingdom0.32%

PortView Portfolio Insights

PortView analyzes how TCHP fits your actual portfolio — position weight, ETF overlap with your other funds, sector and geographic exposure, concentration, and how this fund contributes to your portfolio risk and return. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze TCHP in PortView →

Related securities

Related stocks

Frequently asked questions

What does TCHP track?
TCHP is the T. Rowe Price Blue Chip Growth ETF, a Other ETF.
What is the expense ratio of TCHP?
Expense ratio data for TCHP is shown on the page when available from our data provider.
What are the largest holdings in TCHP?
Top holdings include NVDA, GOOG, AVGO, GOOGL, MSFT.
How can PortView analyze TCHP overlap with other ETFs?
PortView computes the holdings overlap between TCHP and the other ETFs and stocks you own, plus your combined sector and geographic exposure, so you can see true diversification.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.